COST-EFFECTIVENESS OF END-OF-LIFE, LIFE-EXTENDING INTERVENTIONS: NICE'S COST-EFFECTIVENESS THRESHOLD EXPLORED

被引：1
|
作者：
Hamerslag, L. [1 ]
Haynes, S. [1 ]
Kusel, J. [1 ]
Costello, S. [1 ]
机构：
[1] Costello Med Consulting Ltd, Cambridge, England
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.070
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A243 / A243
页数：1
相关论文
共 50 条
  • [1] NICE'S COST-EFFECTIVENESS THRESHOLD REVISITED: NEW EVIDENCE ON THE INFLUENCE OF COST-EFFECTIVENESS AND OTHER FACTORS ON NICE DECISIONS
    Devlin, N.
    Dakin, H.
    Rice, N.
    Parkin, D.
    O'Neill, P.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A246 - A246
  • [2] Cost-effectiveness of life-saving interventions
    Dini, JW
    [J]. PLATING AND SURFACE FINISHING, 1998, 85 (09): : 72 - 73
  • [3] The NICE cost-effectiveness threshold - What it is and what that means
    McCabe, Christopher
    Claxton, Karl
    Culyer, Anthony J.
    [J]. PHARMACOECONOMICS, 2008, 26 (09) : 733 - 744
  • [4] Cost-effectiveness considerations at NICE
    Rawlins, Michael
    Dillon, Andrew
    [J]. LANCET, 2008, 372 (9646): : 1302 - 1302
  • [5] Evaluation of the Role and Cost-Effectiveness of End-of-Life Orthopaedic Interventions in Cancer Patients with Skeletal Metastases to the Hip
    Singh, Gurpal
    Lim, Chin Tat
    Jonathan, Tan Jiong Hao
    Nathan, Saminathan Suresh
    [J]. JOURNAL OF PALLIATIVE CARE, 2013, 29 (02) : 83 - 90
  • [6] Quality of life and cost-effectiveness of treatment
    Finlay, AY
    Henley, LA
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 1997, 8 (01) : 28 - 29
  • [7] Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
    Erik Landfeldt
    [J]. PharmacoEconomics - Open, 2019, 3 : 279 - 280
  • [8] Determination of a cost-effectiveness threshold for cancer interventions in Iran
    Safari, Hossein
    Poder, Thomas G.
    Afshari, Somayeh
    Nahvijou, Azin
    Arab-Zozani, Morteza
    Moradi, Nasrin
    Ameri, Hosein
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
    Landfeldt, Erik
    [J]. PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 279 - 280
  • [10] Cost-effectiveness of Investment in End-of-Life Home Care to Enable Death in Community Settings
    Isenberg, Sarina R.
    Tanuseputro, Peter
    Spruin, Sarah
    Seow, Hsien
    Goldman, Russell
    Thavorn, Kednapa
    Hsu, Amy T.
    [J]. MEDICAL CARE, 2020, 58 (08) : 665 - 673
12345